Ecovyst Inc. (ECVT) stock
ECVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3050% above fair value
$10.75−0.07 (-0.65%)
Close on Nov 12, 2026Market cap $1.18BP/E 33.6Yield –
Ecovyst EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ecovyst's EPS for the twelve months ending Sep 30, 2026 was $0.32. For fiscal 2025 it was -$0.61. The highest annual figure on record is $0.60 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.61 | – |
| FY2024 | Dec 31, 2024 | -$0.06 | -110.0% |
| FY2023 | Dec 31, 2023 | $0.60 | +9.1% |
| FY2022 | Dec 31, 2022 | $0.55 | – |
| FY2021 | Dec 31, 2021 | -$1.02 | – |
| FY2020 | Dec 31, 2020 | -$2.04 | -445.8% |
| FY2019 | Dec 31, 2019 | $0.59 | +37.2% |
| FY2018 | Dec 31, 2018 | $0.43 | -17.3% |
| FY2017 | Dec 31, 2017 | $0.52 | – |
| FY2016 | Dec 31, 2016 | -$1.02 | -300.0% |
| FY2015 | Dec 31, 2015 | $0.51 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.16 | – |
| Q2 FY2026 | Jun 30, 2026 | $0.07 | +40.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.04 | – |
| Q4 FY2025 | Dec 31, 2025 | $0.05 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.69 | -675.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.05 | -28.6% |
| Q1 FY2025 | Mar 31, 2025 | -$0.03 | -400.0% |
| Q4 FY2024 | Dec 31, 2024 | -$0.26 | -200.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.12 | -14.3% |
| Q2 FY2024 | Jun 30, 2024 | $0.07 | -68.2% |
| Q1 FY2024 | Mar 31, 2024 | $0.01 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.26 | +30.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.14 | -12.5% |
| Q2 FY2023 | Jun 30, 2023 | $0.22 | +57.1% |
| Q1 FY2023 | Mar 31, 2023 | -$0.01 | -116.7% |
| Q4 FY2022 | Dec 31, 2022 | $0.20 | +11.1% |
| Q3 FY2022 | Sep 30, 2022 | $0.16 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.14 | – |
| Q1 FY2022 | Mar 31, 2022 | $0.06 | – |
| Q4 FY2021 | Dec 31, 2021 | $0.18 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.52 | -966.7% |
| Q2 FY2021 | Jun 30, 2021 | -$0.01 | -108.3% |
| Q1 FY2021 | Mar 31, 2021 | -$0.68 | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.22 | -1210.0% |
| Q3 FY2020 | Sep 30, 2020 | $0.06 | -57.1% |
| Q2 FY2020 | Jun 30, 2020 | $0.12 | -47.8% |
| Q1 FY2020 | Mar 31, 2020 | $0.00 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $0.20 | -4.8% |
| Q3 FY2019 | Sep 30, 2019 | $0.14 | +27.3% |
| Q2 FY2019 | Jun 30, 2019 | $0.23 | +91.7% |
| Q1 FY2019 | Mar 31, 2019 | $0.02 | – |
| Q4 FY2018 | Dec 31, 2018 | $0.21 | -57.1% |
| Q3 FY2018 | Sep 30, 2018 | $0.11 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.12 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.00 | – |
| Q4 FY2017 | Dec 31, 2017 | $0.49 | +390.0% |
| Q3 FY2017 | Sep 30, 2017 | -$0.03 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.02 | – |
| Q1 FY2017 | Mar 31, 2017 | -$0.02 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.10 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?